| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner +3 more
10 companies
Fairmount Funds Management LLC is a Director, 10% Owner at GLTO with holdings across 10 companies. Recent SEC Form 4 filings include 9 buys and 1 sell.
Estimated insider holdings value: $928.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | COGT Cogent Biosciences, Inc. | Director | Sell | 7,000,000 | $34.66 | $242,620,000.00 | -56.0% | - | - | |
| Dec 4, 2025 | CBIO Crescent Biopharma, Inc. | Director, 10% Owner | Buy | 1,360,000 | $13.41 | $18,237,600.00 | +98.0% | -11.5% | - | |
| Oct 23, 2025 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner | Buy | 454,545 | $22.00 | $9,999,990.00 | +13.1% | +46.3% | - | |
| Oct 7, 2025 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 316,219 | $19.00 | $6,008,161.00 | +16.7% | -20.3% | - | |
| Jul 10, 2025 | COGT Cogent Biosciences, Inc. | Director | Buy | 2,777,777 | $9.00 | $24,999,993.00 | +44.6% | +43.6% | - | |
| Sep 16, 2024 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 300,000 | $17.00 | $5,100,000.00 | +23.0% | -51.2% | +1.5% | |
| Sep 13, 2024 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner | Buy | 1,600,000 | $18.75 | $30,000,000.00 | +86.7% | -18.4% | -14.5% | |
| Jan 22, 2024 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner, See Remarks | Buy | 476,190 | $21.00 | $9,999,990.00 | +34.9% | -28.5% | -7.9% | |
| Sep 29, 2023 | DNTH Dianthus Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 24,670 | $13.63 | $336,252.10 | +1.3% | -25.9% | +99.3% | |
| Sep 26, 2023 | DNTH Dianthus Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 30,000 | $13.15 | $394,500.00 | +1.6% | -12.7% | +102.5% |